Overview

A Clinical Study to Investigate the Long-term Safety of the Drug Macitentan in Patients With Pulmonary Hypertension Who Were Previously Treated With Macitentan in Clinical Studies.

Status:
Enrolling by invitation

Trial end date:
2022-12-16

Target enrollment:

Participant gender:

Summary

The aim of the trial is to study the long-term safety of macitentan and to provide continued treatment with macitentan to patients with pulmonary arterial hypertension (PAH) and Chronic thromboembolic pulmonary hypertension (CTEPH) who were previously treated with macitentan in clinical studies.

Phase:

Phase 3

Details

Lead Sponsor:

Actelion

Treatments:

Macitentan